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Deep into that darkness peering, long I stood there wondering, fearing… 
From The Raven by Edgar Allan Poe 1845
  
ABSTRACT 
Hantaviruses belong to the Bunyaviridae family of negative stranded RNA viruses. They 
carry a tri-segmented genome and consist of four structural proteins. The four structural 
proteins are two glycoproteins Gn and Gc, a nucleocapsid (N) protein and an RNA-dependent 
RNA-polymerase. An additional nonstructural protein can be expressed by some 
hantaviruses. Hantavirus-infection cause two severe diseases in humans with potential deadly 
outcome, namely hemorrhagic fever with renal syndrome (HFRS) or hantavirus cardio-
pulmonary syndrome (HCPS). One main target for hantavirus-infection is the endothelial 
cells and vascular leakage is a hallmark for both HFRS and HCPS. In patients strong 
cytotoxic lymphocyte responses are seen. Cytotoxic lymphocytes, such as natural killer (NK) 
cells and cytotoxic T lymphocytes, cause apoptosis in virus-infected cells via the cytotoxic 
granule pathway or the death receptor pathway. The cytotoxic granule pathway uses 
granzyme B to facilitate programmed cell death (PCD) in the target. The death receptor 
pathway uses death ligands, among them tumor necrosis factor related apoptosis-inducing 
ligand (TRAIL) binds to death receptor (DR) 4 or 5, to induce PCD.  
One potential mechanism regarding hantavirus pathogenesis might be killing of infected 
endothelial cells by cytotoxic lymphocytes, thus causing leakage of the endothelium. This is 
contradicted by findings showing that in patient autopsy, hantavirus-infected cells are intact. 
The aim of this PhD thesis is to give a possible explanation of this dichotomy and to better 
understand hantavirus pathogenesis. 
The first part of this thesis (paper I and II) shows that hantavirus-infection protects cells 
from cytotoxic lymphocytes via inhibiting granzyme B activity and by down-regulating DR5 
from the cell surface. Granzyme B and caspase 3, enzymes needed for apoptosis (a type of 
PCD), both interacts with hantavirus N protein, and they are both inhibited by the N protein. 
Further, hantavirus-infection of primary endothelial cells causes miss-localization of DR5. In 
infected cells DR5 is found in the nucleus instead of on the cell surface. Taken together, 
hantavirus-infection blocks the two major pathways used by cytotoxic lymphocytes to induce 
cell death, suggesting that hantavirus pathogenesis is not due to killing of infected cells by 
cytotoxic lymphocytes. The last part of this thesis (paper III) focuses on hantavirus activated 
NK cell mediated killing of uninfected endothelial cells. NK cells co-incubated with 
hantavirus-infected endothelial cells are activated. This activation is contact dependent and 
was attributed to IL-15 and IL-15Rα expression on hantavirus-infected cells’ surface. 
Interestingly, these activated NK cells induce cell death in uninfected cells with normal HLA 
class I levels, indicating that hantavirus might cause NK cell mediated killing of uninfected 
bystander cells.  
Taken together, the papers I, II and III included in this thesis shows that hantavirus-
infection protects cells from cytotoxic lymphocyte mediated killing, while infected cells can 
cause NK cell activation and possibly subsequent NK cell killing of uninfected cells.  
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1 INTRODUCTION 
ABOUT HANTAVIRUSES 
 
Hantavirus, Orthobunyavirus, Phlebovirus, Nairovirus and Tospovirus are five genera of 
viruses belonging to the Bunyaviridae family. There are human pathogens among four of 
these genera and one, Tospovirus, is only pathogenic in plants. The pathogenic hantaviruses 
may cause hemorrhagic fever in humans, and in most cases humans are considered as dead-
end host for these viruses. Pathogenic hantaviruses are rodent borne in contrast to the other 
genera of bunyaviruses, which are arthropod borne.   
 
The history 
In 1913 clinical records from Russia describes a disease which is now designated as 
hemorrhagic fever with renal syndrome (HFRS) (Johnson, 2001). Although, already around 
A.D. 960, in Chinese medical archives, a similar disease was described. This illness, HFRS, 
have occasionally been referred as a disease of wars. “Field nephritis”, which befell soldiers 
from both the allied and the German troops during World War I, might also have been a 
similar disease. Japanese military faced a similar disease in the1930s after their invasion of 
Manchuria. In World War II Finish and German soldiers encountered similar disease 
(Johnson, 2001). United Nations troop stationed in Korea during 1950s was challenged by 
Korean hemorrhagic fever (Smadel, 1953), now known as HFRS (Johnson, 2001), which 
now is known to be caused by the prototypical hantavirus, Hantaan Virus (HTNV) (Johnson 
2001).  
Efforts to isolate the agents of one of these diseases yielded results in 1976, published 
1978, when the pathogen causing HFRS was characterized (Lee et al., 1978; Johnson, 2001). 
HTNV was discovered in the lungs of a field mouse, captured near the river Hantaan in South 
Korea. Next, in 1980, the HFRS causing Puumala virus (PUUV) was isolated from a bank 
vole caught in Puumala, a municipality in Finland (Brummer-Korvenkontio, et al., 1980). 
Within a couple of years, in 1982, a new hantavirus, the HFRS causing Seoul virus (SEOV) 
was isolated in rats from Seoul, South Korea (Lee et al., 1982).  In 1992, yet another 
hantavirus that cause HFRS was characterized, Dobrava virus (DOBV), in former Yugoslavia 
(Avsic-Zupanc et al., 1992).  
Hantaviruses are known to be the causative agent of both HFRS and hantavirus cardio-
pulmonary syndrome (HCPS; also known as hantavirus pulmonary syndrome, HPS). The 
story of HCPS leads us to the Americas. An outbreak of a disease with respiratory distress, in 
1993 in the four corner region (Arizona, Colorado, New Mexico and Utah) in USA, led to the 
finding of Sin Nombre virus (SNV) (Nichol et al., 1993). In 1995, another HCPS causing 
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virus was discovered, Andes virus (ANDV), in Argentina (López et al., 1996), which like 
SNV cause high case fatality rate.  
It has to be mentioned, a non-pathogenic hantavirus, Thottampalayam virus (TPMV) was 
already described in the early 70s (Carey et al., 1971), therefor probably the first 
characterized hantavirus. 
 
Host and distribution  
Having animal reservoirs as their hosts, hantaviruses are zoonotic viruses (Jonsson et al., 
2010). Pathogenic hantaviruses are carried by rodents, however, hantaviruses can be found in 
insectivores and also, as recently described by Gou and colleagues, in bats (Guo et al., 2013). 
In nature hantavirus-infection of rodents is persistent, and it is thought that the virus has 
coevolved with its host (Meyer and Schmaljohn, 2000). This persistent infection cause 
continuous virus replication during the entire life of the rodent (Jonsson et al., 2010). Humans 
are believed to be dead-end hosts and are accidently infected by inhaling virus contaminated 
rodent excreta (Vaheri et al., 2013). ANDV is the only hantavirus so far known to cause 
human-to-human transmission (Wells et al., 1997). Pathogenic hantaviruses can be found 
worldwide, HFRS causing hantaviruses are mainly found in Eurasia and HCPS causing 
hantaviruses are found in the Americas (Manigold and Vial, 2014).   
 
 
Figure 1. Hantavirus hosts and distribution of the hosts. Reprinted from Gou et al., 2013. PLoS Pathog. 
2013;9(2):e1003159 (Guo et al., 2013) under the terms of the Creative Commons Attribution License.    
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Diseases 
HFRS and HCPS have distinct clinical manifestation with similarities and dissimilarities. 
One of the common hallmarks is vascular leakage. Another shared feature is 
thrombocytopenia, which may add to symptoms involving bleeding (Zaki et al., 1995; 
Kanerva et al., 1998; Vapalahti et al., 2003; Rasche et al., 2004; Latus et al., 2015). Both of 
the diseases can have lethal outcome. HFRS causes up to 15% case fatality (around 0.5-15% 
depending on the virus), and HCPS causes up to 40% case fatality (Vaheri et al., 2013). 
 The incubation time for HFRS is normally between one to six weeks, which is followed 
by a febrile phase with flu like symptoms, such as myalgia, headache, abdominal pain and 
malaise, and occasionally also neurological, cardiovascular and gastrointestinal symptoms 
(Hautala et al., 2012). Hemorrhage may occur, afterward the patients enter a hypotensive 
phase with symptoms of vascular leakage, associated with thrombocytopenia, and sometimes 
shock. The resulting oliguric phase can last up to five days with risk for hypertension, 
pulmonary edema and renal failure. After the subsequent diuretic phase, the convalescent 
phase starts. Unfortunately for some HFRS patients the outcome may be fatal (Nichol 2001; 
Vaheri et al., 2013; Manigold and Vial 2014).  
Incubation time for HCPS ranges from two to six weeks (Vial et al., 2006; Jonsson et al., 
2008; MacNeil et al., 2011). Comparable to HFRS, the HCPS patients exhibits fever, 
myalgia, headache, and malaise. Sometime gastrointestinal, and neurological signs might be 
seen, additionally, thrombocytopenia, leukocytosis and leucopenia have been reported, and 
increased creatinine levels, hyponatremia and proteinuria (Hallin et al., 1996; Duchin et al., 
1994; Castillo et al., 2001; Riquelme et al., 2003). The cardiopulmonary phase consist of 
dyspnea, cough, tachycardia and hypotension, which reflect rapidly progressive pulmonary 
edema caused by capillary leakage and low cardiac output, which can lead to cardiac failure 
(Talamonti et al., 2011).  Rapid progression of HCPS might lead to death within 48 hours 
(Vial et al., 2013; Manigold and Vial, 2014).  Currently, there is no worldwide-approved 
vaccine or clinically approved drugs for HCPS or HFRS.  
 
Structure 
Hantavirus, as all bunyaviruses are tri-segmented negative sense RNA virus.The three 
segments are designated large, medium and small segment (Schmaljohn et al., 1983a, 
Schmaljohn and Dalrymple, 1983b). For hantaviruses these segments are around 6500, 3600, 
and 1700-2000 nucleotides long respectively. Each RNA segment contains an open reading 
frame, and is flanked by non-coding regions (Plyusnin et al., 1996; Vaheri et al., 2013.). The 
both end termini of the non-coding regions are complementary to each other and form a 
panhandle structure. Four structural proteins are encoded by these RNA segments, the large 
segment encodes a RNA-dependent RNA polymerase (RdRp), the medium segment encodes 
a precursor glycoprotein which later is processed into two glycoproteins (Gn and Gc), and the 
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small segment encodes a nucleocapsid (N) protein. These four proteins together with the 
virus RNA segments and cellular membrane forms an enveloped virus which is around 120-
160 nm, with a pleomorphic shape (Figure 2) (Vaheri et al., 2013).  
 
 
Figure 2. Schematic illustration of a hantavirus particle. 
 
Hantavirus proteins 
Expressing only few proteins mean that some or all of the virus proteins should have 
more than one function for successful virus propagation. The RdRp, a 250 KDa protein, have 
RNA transcriptase and replicase activity, and it was also demonstrated that RdRp has a 
perinuclear localization (Kukkonen et al., 2004; Kukkonen et al., 2005). Since hantaviruses 
are negative strand viruses the RdRp must be carried by the virus in order for it to replicate.   
The hantavirus glycoproteins seem to have several functions, though most of them are 
linked to host receptor recognition (Klingström and Ahlm, 2011). Initially, the Gn and Gc are 
translated as one single glycoprotein precursor, which is later cleaved after a conserved 
WAASA motif (Löber et al., 2001). The glycoproteins have key roles in virus attachment and 
binds to several receptors (Vaheri et al., 2013). Besides surface receptors, the glycoproteins 
also interact with intracellular host proteins (Klingström and Ahlm 2011).  Trafficking of 
Glycoproteins 
RdRp 
N 
Virus RNA 
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arenavirus, hantavirus, coronavirus, orthomyxovirus, and filovirus glycoproteins requires 
endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) pathway (Klaus et 
al., 2013). New York 1 virus (NY-1) Gn protein inhibits interferon (IFN) responses by 
interaction with retinoic acid-inducible gene I (RIG-I) and tumor necrosis factor (TNF) 
receptor-associated factor 3 (TRAF3) (Alff et al., 2006; Allf et al., 2008). IFN responses can 
also be down-regulated by inhibition of STAT1 phosphorylation by hantavirus glycoproteins 
(Spiropoulou et al., 2007). These data indicates that hantavirus glycoproteins are not only 
essential for attachment to the cell surface, they also have important roles in the regulation of 
host immune responses.   
Probably the most studied hantavirus protein is the N protein, and it has been shown that 
this specific protein can interact with different host proteins and it harbors various functions 
(Klingström and Ahlm, 2011; Vaheri et al., 2013). Black Creek Canal virus N protein 
interacts with actin microfilament and actin is important for Black Creek Canal virus progeny 
release (Ravkov et al., 1998). HTNV N protein is distributed along microtubule and is 
colocalized with the ERGIC (Ramanathan et al., 2007). It has also been described that ANDV 
N, Black Creek Canal virus N, SEOV N also use microtubule (Ramanathan and Jonsson, 
2008). Together, showing that hantavirus N protein interact with host cytoskeleton, and the 
host proteins are essential for virus propagation, as disrupting the host cytoskeleton impaired 
virus propagation. HTNV can cause expression of heat shock protein 70 (Hsp70) and HTNV 
N protein forms a complex with Hsp70 (Ye et al., 2001), but overexpression of Hsp70 was 
suggested to be disadvantageous for virus propagation (Yu et al., 2009). Pull down assay 
showed that PUUV N protein interacts with death-domain associated protein-6 (DAXX) (Li 
et al., 2002), indicating that hantavirus may have the ability to interact with cell death 
pathways. Further, it has been proposed that SNV N protein replaces eukaryotic initiation 
factor 4F, suggesting that N protein might be able to directly facilitate translation initiation 
(Mir and Panganiban, 2008). Binding of HTNV N to importin-α proteins has been reported 
and this binding caused inhibition of nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) signals by obstructing importin-α-mediated transport of NF-κB to the nucleus 
(Taylor et al., 2009a). HTNV N protein also directly interacts with NF-κB (Ontiveros et al., 
2010). ANDV N protein is an inhibitor of both granzyme B and caspase 3, thus also able to 
inhibit apoptosis, and both theses enzymes can cleave the N protein (paper I). These are 
some examples of the host proteins that hantavirus N protein interact with, showing how one 
single virus protein can be used in different ways by the virus during its lifecycle. 
Certain hantaviruses, such as Tula virus (TULV), PUUV and ANDV, may in the 
infected cells express a nonstructural protein (NSs) (Jääskeläinen et al., 2007; Jääskeläinen et 
al., 2008; Vera-Otarola et al., 2012). The role for ANDV NSs has yet to be defined. However, 
TULV and PUUV NSs have been suggested to interfere with IFN responses (Jääskeläinen et 
al., 2007; Jääskeläinen et al., 2008). The localization of TULV NSs is in the pernuclear 
region of the infected cell (Virtanen et al., 2010).  
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Life cycle 
The life cycle of hantavirus starts with attachment and binding of the virus to its cellular 
receptors. There are several known receptors that hantaviruses binds to; αVβ3 integrin 
(Gavrilovskaya et al., 1998; Gavrilovskaya et al., 1999), complement decay-accelerating 
factor (Krautkrämer and Zeier, 2008), a glycosylphosphatidylinositol-anchored protein of the 
complement system, GC1QR (globular heads of complement C1q receptor; also known as 
C1QBP) (Choi et al., 2008), and an unidentified 70 KDa protein (Mou et al., 2006).  
Entry into the cells differs between HFRS and HCPS causing hantaviruses, HFRS 
causing viruses use clathrin dependent endocytosis, while the exact entry mechanism of 
HCPS causing hantaviruses remains unknown (Jin et al., 2002; Ramnathan and Jonsson 
2008). Other ways of entry than clathrin dependend endocytosis has been shown for other 
bunyaviruses. For example, phleboviruses enters the cell through penetration of host cell by 
acid-activated membrane fusion (Lozach et al., 2010). Inside the cell the hantaviruses are 
transported via the early and late endosomes, where lowering of pH leads to detachment of 
virus particles (Jin et al., 2002).  
As there is a lack of reverse genetics for hantaviruses, studies of virus transcription and 
replication have been limited. Attempt at making reverse genetics for hantaviruses was made 
(Flick et al., 2003), but this has not been successfully repeated again. 
 The replication and transcription of hantaviruses are thought to be similar to other 
bunyaviruses. mRNA and negative stranded genomic virus RNA is produced by the RdRp 
(Kukkonen et al., 2005). The negative strand virus RNA is replicated to positive strand 
complementary RNA which is then replicated to negative strand virus RNA. In order to make 
new virus proteins, negative strand virus RNA is transcribed to mRNA leading to subsequent 
translation of virus proteins (Jonsson and Schmaljohn, 2001; McAllister and Jonsson, 2014; 
Vaheri et al., 2013).  
When replication is performed, the virus genomes are encapsidated by N proteins 
(Hepojoki et al., 2012). It is not exactly known where the assembly of the virus particle takes 
place, the HFRS causing hantaviruses have been suggested to be assembled and matured in 
the Golgi where budding of the virus particle occurs, and the virion exit the cell through 
exocytosis. Whereas, for HCPS causing hantaviruses it has been proposed that assembly 
might occur at the host plasma membrane (Jonsson and Schmaljohn, 2001; McAllister and 
Jonsson, 2014; Vaheri et al., 2013).     
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IMMUNOLOGY AND HANTAVIRUSES 
 
Classically, our immune system is divided in two parts: the innate immunity (also known as 
natural or native immunity) and the adaptive immunity (sometime referred as acquired or 
specific immunity). These two parts of the immune system is critical for host defense against 
pathogenic agents.  The innate immune system uses pattern recognition receptors (PRRs) to 
sense infection and mount an immune response. This will lead to induction of interferons 
(IFN) and recruitment of immune cells such as natural killer (NK) cells and dendritic cells 
(DC). DCs bridges the innate immune system with the adaptive immune system. When the 
adaptive immune system is active, cytotoxic T lymphocytes (CTL) are activated. Both NK 
cells and CTLs can kill infected target cells.  
 
Pattern recognition receptors  
Virus RNA can be recognized as pathogen-associated molecular patterns (PAMPs) by 
PRRs in infected cells, and by that activate innate immune responses (Kato et al., 2006; Kato 
et al., 2008). There are different types of PRRs: toll like receptors (TLRs), nucleotide-binding 
oligomerization domain receptors (NLRs), and RIG-I-like receptors (RLRs) are some 
example of PRRs used by cells to sense virus-infection.  
Nucleic acids can be recognized by TLRs, which play a pivotal role in recognizing virus 
infection (Chow et al., 2015). Different TLRs recognizes different types of PAMPs: double-
stranded virus RNA is recognized by TLR3 (Alexopoulou et al., 2001), single stranded virus 
RNA is recognized by TLR7 and TLR8 (Diebold et al., 2004; Heil et al., 2004), DNA 
containing unmethylated CpG can be recognized by TLR9 (Lund et al., 2003). There have 
been some reports regarding TLRs during hantavirus-infection. HTNV triggers TLR3 and 
causes innate immune responses and inflammatory responses (Handke et al., 2009; Zhang et 
al., 2014). Hantavirus triggers TLR4 and antiviral immunity through MyD88 pathway (Yu et 
al., 2012), and it has also been shown that HTNV-infection induces TLR4 expression that 
may enhance the host immune responses (Jiang et al., 2008).  
The RLR family consist of RIG-I, melanoma differentiation-associated gene 5 (MDA-5), 
and laboratory of genetics and physiology-2 (Nan et al., 2014). RLRs are cytoplasmic 
receptors that detects virus RNA in the cytosol (Schlee, 2013). RIG-I recognizes double 
stranded RNA, then recruits caspases and activates NFκB and by that inducing IFN responses 
(Yoneyama et al., 2004). Several studies have shown that RIG-I and MDA-5 can detect RNA 
viruses (Nan et al., 2014). For example, phlebovirus and dengue virus are recognized by RIG-
I (Habjan et al., 2008; Nasirudeen et al., 2011; Ning et at., 2014). Evidently there are viruses 
that can evade RLRs. For example, arenaviruses use decoys to avoid detection by RIG-I, by 
using a single unpaired 5' ppp-nucleotide that render RIG-I incapable of inducing IFN 
responses (Marq et al., 2010; Marq et al., 2011). It has been suggested that HTNV-infection 
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might be recognized by RIG-I and MDA-5 (Zhang et al., 2014; Lalwani et al., 2013; Lee et 
al., 2011), although hantavirus genomic RNA by itself is not sufficient to trigger recognition 
by RIG-I (Habjan et al., 2008). Additional complexity is added to hantavirus-infection and 
RIG-I interaction as several reports show that hantavirus Gn protein inhibits RIG-I (Alff et 
al., 2006; Matthys et al., 2014). 
The NLR family of PRRs consist of nucleotide-binding oligomerization domain (NOD), 
leucine-rich repeat (LRR) and PYD domains-containing protein (NLRPs; also known as 
NALPs) (Schroder and Tschopp, 2010). Of the NLR family NLRP3 is the only PRR that has 
been shown to recognize viruses. Activated NLRP3 triggers the formation of the 
inflammasome. Inflammasomes contain caspase 1, and actived caspase 1 in turn cleaves IL-
1β. The cleaved processed IL-1β is secreted and causes inflammation (Tschopp and Schroder 
2010). Several viruses have been described to interact with NLRP3: influenza A virus 
(McAuley et al., 2013; Pothlichet et al., 2013), respiratory syncytial virus (Segovia et al., 
2012), Rift Valley fever virus (Ermler et al., 2014) and many more (Jacobs and Damania, 
2012). It has recently been described that HTNV cause IL-1β secretion in human monocytes 
through NLRP3 inflammasome activated caspase 1 (Ye et al., 2015).  
 
Nuclear factor kappa-light-chain-enhancer of activated B cells 
NFκB is activated by PRRs upon virus infection and this activation causes IFN responses 
(Zhao et al., 2015). Adapter molecules of PRRs recruits TRAF (Nan et al., 2014), which 
subsequently in a cascade of events lead to degradation of inhibitor of κB (Zandi et al., 1997; 
Zhao et al., 2015). NFκB is activated following the degradation of inhibitor of κB, and the 
active NFκB is transported to the nucleus, where it induce transcription and subsequent 
translation of various cytokines and other proteins to mount a strong innate immune response 
(Zandi et al., 1997). As a consequence, some viruses have evolved strategies to evade NFκB 
signaling pathways. For instance, Epstein–Barr virus deubiquitinates TRAF6 (Saito et al., 
2013), and HSV-1 blocks activation of NFκB (Xing et al., 2013; Wang et al., 2014) and 
varizella zoster virus blocks translocation of NFκB to the nucleus (Sloan et al., 2012). HTNV 
N protein blocks NFκB translocation to the nucleus via interaction with importin alpha 
proteins, as well as inhibiting TNF-induced activation of NFκB (Taylor et al., 2009a; Taylor 
et al., 2009b). The N protein of HTNV can directly bind to NFκB, but the effect of this 
finding remains to be explored (Ontiveros et al., 2010).  
 
Interferons 
IFNs play an essential role during virus infection. They are used by infected cells to 
signal the neighboring cells to enter an antiviral state, thus limiting spread of virus. IFNs also 
have direct antiviral effect on virus-infected cells including by inducing apoptosis (Clemens, 
2003; McInerney and Karlsson Hedestam, 2009). There are three types of IFNs, type I 
  9 
(among them, IFN-α and IFN-β are most studied), II (includes only IFN-γ) and III (several 
type of IFN-λ) (Chelbi-Alix and Wietzerbin, 2007). Any nucleated cell can produce IFN-α/β 
(Chelbi-Alix and Wietzerbin, 2007) but plasmacytoid dendritic cells are the main producers 
of IFN-α (Barchet et al., 2002). Type III IFNs, IFN-λ, do have antiviral activity similar to the 
type I IFNs, although with weaker effects (Kotenko et al., 2003; Sheppard et al., 2003).  
Studies of IFN induction by dsRNA viruses led to the discovery of IFN regulatory factors 
(IRFs) during the late 80’s (Miyamoto et al., 1988). IRFs are required for both IFN-α/β 
production, as IRFs promotes induction of IFNs (Randall and Goodbourn, 2008). Upon virus 
recognition by RIG-I or MDA5, these PRRs signal via the mitochondrial adaptor protein 
(Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005), and recruits and 
activates IRFs and NFκB.  Activated IRF and NFκB are translocated to the nucleus where 
they attach to the IFN promoter and type I IFNs are expressed (Zandi et al., 1997; McInerney 
and Karlsson Hedestam, 2009; Zhao et al., 2015). After being secreted IFN binds to 
interferon-α/β receptor and type I IFN signals through the JAK-STAT (JAK; janus kinase, 
STAT; signal transducer and activator of transcription) pathway, to activate STAT1/2 by 
phosphorylation. Phosphorylated STAT1/2 are transported to the nucleus, where more IFNs 
and IFN stimulated genes are transcribed.  
Due to the strong antiviral capacity of IFNs some viruses have evolved strategies to 
inhibit induction of IFNs. For example, cytomegalovirus (CMV), Hepatitis B and C virus, 
and Hendra virus targets STAT1 and/or STAT2 to block induction of IFNs (Rodriguez et al., 
2003; Paulus et al., 2006; Lin et al., 2006; Wu et al., 2007). 
Both HCPS and HFRS causing hantaviruses inhibit STAT1/2 phosphorylation and 
thereby inhibit the antiviral ability of IFNs (Spiropoulou et al., 2007; Stoltz et al., 2007). 
Other ways that hantaviruses inhibit induction of type I IFNs is by inhibition of RIG-I 
(Matthys et al., 2014). It has also been shown that hantavirus N protein and glycoproteins 
antagonize type I IFNs (Alff et al., 2006; Alff et al., 2008; Levine et al., 2010; Matthys et al., 
2014). Very recently, it has been suggested that PUUV-infection cause IFN type I-induced 
STAT1-dependent expression of tissue plasminogen activator (Strandin et al., 2015). 
Pretreatment of cells with IFN-λ alone have antiviral effect on HTNV replication (Stoltz et 
al., 2007). Later it was also demonstrated that HTNV can cause type I IFN independent 
induction of IFN-λ (Stoltz and Klingström, 2010), and that HCPS causing hantaviruses 
induce high levels of IFN-λ secretion (Prescott et al., 2010). Altogether, hantaviruses induce 
type III IFN production and have mechanisms to inhibit the induction of type I IFNs and the 
antiviral effect of IFNs. 
 
Dendritic cells 
DCs were discovered 1973 by Steinman (Steinman and Cohn, 1973) and this finding was 
awarded the Nobel Prize 2011. DCs are professional antigen presenting cells that are 
considered to be the initiator and modulator of the adaptive immune response and they 
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bridges the innate immune system with the adaptive immune system (Banchereau and 
Steinman, 1999).There are different sets of DCs, classical DCs (cDCs), plasmacytoid DCs 
(pDCs), Langerhans cells (LCs), and monocyte-derived DCs (moDCs) (Murphy et al., 2015). 
DCs can experimentally be infected by both HFRS and HCPS causing hantaviruses, and a 
result of this is that proinflammatory cytokines, TNF and IFN-α, are released (Raftery et al., 
2002; Markotic et al., 2007; Marsac et al., 2011). Further, DCs infected with hantavirus might 
stimulate T cells (Raftery et al., 2002).  
 
Natural killer cells  
NK cells play important roles in early host responses against virus-infection. NK cells 
can be activated by various cytokines, such as IFN-α, IFN-β, interleukin-2 (IL-2), IL-12, IL-
15 and IL-18 (Jost and Altfelt, 2013). The antiviral effect of NK cells are to directly destroy 
target infected-cells or produce antiviral, immune stimulatory and proinflammatory 
cytokines, such as IFN-γ and TNF, which might act on the virus-infected cells and 
surrounding cells (Jost and Altfelt, 2013). The way NK cells recognizes infected cells is by a 
manner referred to as the “missing self-recognition”. NK cells upon detecting cells that lack, 
or have reduced, major histocompatibility complex class I, also known as human leukocyte 
antigen (HLA) class I, on their cell surface, kill the target infected-cell (Kärre et al., 1986; 
Ljunggren et al., 1990). NK cells uses different ways to kill virus-infected cells, either 
through cytotoxic granule-mediated apoptosis or via death receptor-mediated apoptosis 
(Shresta et al.; 1998; Zamai et al., 1998; Sato et al., 2001; Lieberman 2003; Chowdhury and 
Lieberman, 2008). Cytotoxic granule contents, such as granzyme B and perforin, are 
delivered into the target cell through the immunological synapse formed between the NK cell 
and the target infected cell. NK cells may also express death ligands on its surface and by 
binding of death ligand to death receptor, expressed on the target cell, kill the target cell. 
 NK cells can be divided into two subgroups, designated CD56bright NK cells and 
CD56dim NK cells. CD56bright NK cells mainly have immunomodulatory effects, specifically 
by producing and releasing IFN-γ and TNF, whereas CD56dim NK cells mainly are involved 
in cellular cytotoxicity. However in specific conditions, both of the NK subgroups can 
produce IFN-γ and TNF, and be cytotoxic (Cooper et al., 2001; Lanier 2008; Björkström et 
al., 2010; Fauriat et al., 2010; Stegmann et al., 2010).  
In order to recognize and react towards target cells, NK cells express different activating 
and inhibitory receptors. The function of a NK cell is determined by the balance between 
stimulated activating and inhibitory receptors (Lanier 2003; Bryceson et al., 2006; Lanier 
2008; Bryceson and Long 2008).  
The role of NK cells during hantavirus-infection is not well known. Increased levels of 
NK cells during hantavirus-infection has been reported (Linderholm et al., 1993; Björkström 
et al., 2011). In the article by Björkström and colleagues in 2011, it was also shown that NK 
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cells are rapidly elevated during HFRS, and strikingly this NK cell elevation persisted up to 
60 days after disease onset. Analysis of HCPS patients also showed elevated levels of 
cytokines that promotes tissue migration of NK cells (Morzunov et al., 2015). In vitro NK 
cells in contact with hantavirus-infected cells get activated, and these activated NK cells 
might be able to kill uninfected cells (paper III). 
 
Cytotoxic T lymphocytes  
CTLs, CD8+ T cells, are an important part of the adaptive immune system during virus 
infection, as they are equipped with various means to eradicate infected cells. Just as NK 
cells, CTLs also uses granzyme B-mediated apoptosis or death receptor mediated apoptosis to 
eradicated virus-infected cell (Jeremias et al., 1998; Shresta et al., 1998; Kayagaki et al., 
1999; Lieberman 2003; Chowdhury and Lieberman, 2008). Antigens, for example viral 
peptides, presented by HLA class I on the surface of the antigen presenting cell are 
recognized by CTLs. This recognition activates CTLs, with the aid of T helper cells. 
Proliferation of CTLs is stimulated by IL-2 (Chaplin, 2010).  
Studies have reported that both HFRS and HCPS patients display increased levels of CD8+ T 
cells (Linderholm et al., 1993; Kilpatrick et al., 2004; Lindgren et al., 2011; Xie et al., 2013). 
Several CTL epitopes, for hantaviruses have been identified and they seem to be restricted 
mainly to the N protein (Asada et al., 1988; Van Epps et al., 1999; Van Epps et al., 2002; 
Wang et al., 2011). CTLs have been suggested to increase vascular permeability by killing 
hantavirus-infected cells (Terajima et al., 2007; Schönrich et al., 2008). CTLs are also 
capable of lysing cells expressing hantavirus N protein, in these studies viral vectors was used 
instead of hantavirus-infection (Van Epps et al., 1999; Van Epps et al., 2002; Safronetz et al., 
2009).  Hantavirus-infections protects cells from cytotoxic granule-mediated and TRAIL-
induced apoptosis, indicating that hantavirus-infected cells should be protected from CTLs 
(paper I and II). 
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PROGRAMMED CELL DEATH 
 
There are various type of cell deaths. Classically cell death used to be divided into necrosis or 
programmed cell death (PCD). The main difference between PCD and necrosis is that PCD is 
controlled and do not cause any adverse effect on the surrounding (D'Amours et al., 2001) 
While necrosis is uncontrolled and leads to tissue inflammation (Kelly et al., 2001). However, 
recently some forms of PCD have been described to cause inflammation (Kroemer et al., 
2009). These two types of cell death have also recently been suggested to be renamed to 
accidental cell death (ACD) and regulated cell death (RCD), by the Nomenclature Committee 
on Cell Death (Galluzzi et al., 2015). The Nomenclature Committee on Cell Death also 
suggest the use of the term PCD only during tissue/organism development or for tissue 
homeostasis. There are many types of RCDs, some examples are apoptosis, necroptosis, 
autophagy, and pyroptosis (Kroemer et al., 2009). Necroptosis and pyroptosis are RCDs 
which in contrast to apoptosis and autophagy induce inflammation (Kroemer et al., 2009). 
Thus both ACD and RCD can induce inflammation (Galluzi et al., 2012; Galluzi et al., 2015). 
If cell death can be prevented therapeutically, then it is considered to be RCD, but if it is 
impossible to hinder the cell death then it counts as ACD (Lettre and Hengartner, 2006; 
Taylor et al., 2008; Fuchs and Steller, 2011; Delbridge et al., 2012). In this thesis I will use 
the term PCD instead of RCD, since the term RCD is not commonly used yet.  
Among the different type of PCDs, apoptosis is the one that is most studied and various 
studies have been performed on the subject of hantaviruses and apoptosis (Kang et al., 1999; 
Markotic et al., 2003; Li et al., 2004; Li et al., 2005; Hardestam et al., 2005; Ontiveros et al., 
2010; Khaiboullina et al., 2013; paper I and II). 
 
Apoptosis 
The term apoptosis was created in 1972 in order to describe detailed morphological 
feature of cell death (Kerr et al., 1972). These morphological aspects are rounding up of the 
cell, retraction of the pseudopodia, reduced cellular volume, nuclear fragmentation, plasma 
membrane blebbing, and in vivo also engulfment by phagocytes. Biochemically, apoptosis is 
defined as caspase-dependent cell death (Taylor et al., 2008; Galluzi et al., 2012). Two types 
of apoptosis can be initiated by either intracellular or extracellular stimuli, designated 
intrinsic apoptosis or extrinsic apoptosis respectively (Galluzi et al., 2015).  One important 
feature of apoptosis is that it is energy dependent (D'Amours et al., 2001), as is the other 
forms of PCDs (Galluzi et al., 2012). 
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Intrinsic apoptosis 
Intrinsic apoptosis can be triggered by many things, for example UV-irradiation, 
starvation, cellular stress etc. These triggers cause release of cytochrome C due to 
mitochondrial outer membrane permeability (MOMP). MOMP is essential for intrinsic 
apoptosis. B-cell leukemia/lymphoma-2 (Bcl-2) family of proteins are important players in 
mitochondrial pathway of apoptosis, and they consist of both anti-apoptotic, such as Bcl-XL, 
Bcl-w, and pro-apoptotic proteins, such as Bax, Bak, Bh3-only family (Cory and Adams, 
2002; Wang and Youle, 2009). Upon stress signal BH3 interacting-domain death agonist 
(Bid) is cleaved to truncated-Bid (tBid), tBid activates Bax and Bak via oligomerization 
causing MOMP and this leads to the release of cytochrome C. Bcl-2 blocks Bax, thus 
hindering cytochrome C release, and Bcl-2 can be inhibited by BH3 domain-containing 
proteins (Cory and Adams, 2002).  During MOMP not only cytochrome C is released but also 
second mitochondria-derived activator of caspase, which can inhibit inhibitor of apoptosis 
protein. The release of cytochrome C leads to the formation of apoptosome by recruitment of 
apoptotic protease activating factor 1 (APAF-1) and caspase 9, then subsequent activation of 
caspase 9, which activates caspase 3 (Liu et al., 1996; Yang et al., 1997; Zou et al., 1997; Li 
et al., 1997; Ow et al., 2008). Hantaviruses can inhibit chemically-induced intrinsic apoptosis 
(paper I). 
 
Extrinsic apoptosis 
The term extrinsic apoptosis is used to define apoptosis caused by extracellular stimuli, 
such as binding of death inducing ligands, including Fas, TNF, TNF-related apoptosis 
inducing ligand (TRAIL), to their cognate death receptors (DR), such as Fas-receptor, TNF-
receptor 1, and death receptor 4 and 5 (DR4, DR5). Extrinsic apoptosis relies on activation of 
caspase 8 and caspase 3 or the MOMP pathway (Scaffidi et al., 1998; Suliman et al., 2001; 
Galluzzi et al., 2012; Galluzzi et al., 2015). TRAIL-induced extrinsic apoptosis is inhibited 
by hantavirus-infection (paper II).   
 
Caspases 
Caspases are cysteine proteases that can cleave their target proteins after aspartic acid 
residues (Riedl and Shi, 2004). All caspases in a cell are zymogens that needs proteolytic 
processing and activation in order to be functional. There are different type of caspases, 
initiator caspases, execution caspases, and inflammatory caspases (Cohen 1997). Caspases 
contain death effector domain, caspase recruitment-domain, a large and a small catalytic 
subunit (Riedl and Shi, 2004; Lavrik et al., 2005). The most important executioner is caspase 
3, and caspase 3 is activated by the initiator caspases 8, 9 and 10. Caspase 3 cleaves inhibitors 
of caspase activated DNase, thus releasing caspase activated DNase, leading to DNA 
degradation and chromatin condensation (Sakahira et al., 1998). There are certain viruses, for 
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example Junin virus, that inhibits caspase 3 activity (Wolff et al., 2013). ANDV N protein is 
also a caspase 3 inhibitor (paper I). 
 
Viruses and apoptosis 
Virus-infection may also cause intrinsic induction of PCD. One such PCD, apoptosis, 
during virus-infection has been well studied. Some examples are; adenovirus that uses several 
mechanism to induce apoptosis (Rao et al., 1992; Marcellus et al., 1996; Marcellus et al., 
1998; Lavoie et al., 1998; Shtrichman and Kleinberger, 1998, Hart et al., 2007), Parvovirus 
B19 causes DNA strand breaks (Op De Beeck and Caillet-Fauquet, 1997), human 
immunodeficiency virus-1 induces apoptosis in various ways (Banda et al., 1992; 
Westendorp et al., 1995; Shi et al., 1996a; Moutouh et al., 1998; Hesselgesser et al., 1998; 
Sasaki et al., 2002), respiratory syncytial virus cause apoptosis via induction of IFNs (Wang 
et al., 1998), the arenavirus Tacaribe virus induces apoptosis in a yet unknown way (Wolff et 
al., 2016), and there are countless other viruses that causes apoptosis (Roulston et al., 1999; 
Galluzzi et al., 2008). On the other hand, viruses also have evolved strategies to either avoid 
apoptosis or even inhibit apoptosis. As there are numerous ways for viruses to cause 
apoptosis there are also various ways used by viruses to evade apoptosis (Galluzzi et al., 
2008). To mention some; cowpox virus and vaccinia virus inhibits caspases (Tewari et al., 
1995; Dobbelstein and Shenk, 1996), adenovirus inhibits apoptosis using different 
mechanisms (Moore et al., 1996; Teodoro and Brenton, 1997; Nevels et al., 1999), and there 
are of course many other apoptotic pathways blocked by several other viruses (Roulston et 
al., 1999, Galluzzi et al., 2008).  
The studies regarding hantaviruses and apoptosis have been conflicting. Some studies 
show that hantaviruses might induce apoptosis (Kang et al., 1999; Markotic et al., 2003; Li et 
al., 2004; Li et al., 2005), but later it was shown that hantaviruses normally do not cause 
apoptosis (Hardestam et al., 2005). It has also been demonstrated that hantaviruses inhibit 
apoptosis (Ontiveros et al., 2010; Khaiboullina et al., 2013; paper I and II).  
Early studies indicated that HTNV and Prospect Hill virus (PHV) cause apoptosis in 
cultured African green monkey kidney epithelial (Vero E6) cells (Kang et al., 1999). Studies 
also showed that HTNV-infection of human embryonic kidney (HEK293) cells render 
neighboring bystander cells prone to apoptosis (Markotic et al., 2003). These differences 
might be due to use of different cell-lines for these studies. Li and colleagues showed Tula 
virus (TULV) caused apoptosis in Vero E6 cells, and this induction of apoptosis was 
attributed to ER stress, and subsequent activation of caspase 8 and caspase 3 (Li et al., 2004; 
Li et al., 2005). Here, the question rises, whether if this apoptosis is specific for TULV or 
could this be due to the cell-line used in these studies. TULV is considered to be a non-
pathogenic hantavirus. Could non-pathogenic hantaviruses could cause apoptosis in vitro? 
There has been reports that TULV cause illness in an immunocompromised patient (Zelená et 
al., 2013), and more interestingly, a very recent report showed that TULV-infection led to 
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hospitalization of a patient without any former medical conditions (Reynes et al., 2015). 
Thus, maybe TULV might be considered a pathogenic hantavirus, which should mean that 
apoptosis caused by hantaviruses may not be attributed only to the non-pathogenic 
hantaviruses. HFRS causing hantaviruses, such as HTNV, DOBV, and PUUV does not 
induce apoptosis in confluent Vero E6 or adenocarcinomic human alveolar basal epithelial 
cells (Hardestam et al., 2005).  
Lately, it has also been revealed that hantaviruses harbor specific strategies to block 
apoptosis, for example, hantavirus-infection might interfere with DAXX mediated apoptosis 
with the aid of the N protein (Khaiboullina et al., 2013). Both HFRS and HCPS causing 
hantaviruses are able to inhibit staurosporine (STS is a broad kinase-inhibitor that induces 
apoptosis (Karaman et al 2008; Manns et al., 2011)) mediated apoptosis (paper I).  
 
Granzyme B-mediated cell death 
Granzyme B is a serine protease and is unique amongst the granzymes, since it is the only 
granzyme that cleaves its target protein after aspartic acid residue. The delivery of granzyme 
B into a target cell is mediated by perforin in a manner not fully understood (Caputo et al., 
1994; Lord et al., 2003; Trapani and Sutton, 2003; Chowdhury and Lieberman, 2008). 
Granzyme B induces apoptosis through directly cleaving and thereby activating caspase 3. In 
vitro, several caspases have been shown to be cleaved by granzyme B, this includes caspase 
1, 2, 3, 6, 7, 8, 9 and 10, but in vivo only caspase 3 and 8 are substrates for granzyme B 
(Darmon et al., 1995; Darmon et al., 1996; Martin et al., 1996; Shi et al., 1996b; Orth et al., 
1996; Chinnaiyan et al., 1996; Duan et al., 1996; Medema et al., 1997; Talanian et al., 1997; 
Yang et al., 1998; Atkinson et al., 1998; Metkar et al., 2003). It has been suggested that 
caspase 3 activation by granzyme B involves both direct activation of caspase 3 and 
liberation from caspase inhibition via the release of inhibitor of apoptosis protein from the 
mitochondria (Sutton et al., 1997; Goping et al., 2003). Granzyme B also cleaves the 
proapoptotic protein Bid into t-Bid directly or via caspase 8. The t-Bid is translocated to 
mitochondria, and activates Bax and Bak, leading to cytochrome C release and subsequent 
induction of apoptosis (Figure 3) (Martinou et al., 1998; Heibein et al., 1999; Sutton et al., 
2000; Alimonti et al., 2001; Zamzami and Kroemer, 2003; Andrade et al., 2004). Caspase 
independent granzyme B mediated cytochrome C release has been proposed as a non- 
apoptotic way of cell death (Figure 3) (Heibein et al., 1999).  
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Figure 3. Illustration of how granzyme b cause cell death. 
 
Many inhibitors of granzyme B have been described (Chowdhury and Lieberman, 2008), 
but for viruses only three inhibitors are known, adenovirus L4-100K assembly protein, 
cowpox virus cytokine response modifier A protein (CrmA) (Tewari et al., 1995; Quan et al., 
1995; Andrade et al., 2001), and hantavirus N protein (paper I). 
 
TRAIL-induced cell death  
TRAIL belongs to the TNF superfamily and it induces cell death (summarized in figure 4) via 
binding to its cognate receptors, DR4 and/or DR5, both of which contain cytoplasmic death 
domains (Schneider et al., 1997a; Schneider et al., 1997b; Falschlehner et al., 2007; 
Falschlehner et al., 2009; Collison et al., 2009). When TRAIL binds to DR4 or DR5, 
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recruitment of Fas-associated death domain protein (FADD) and pro-caspase 8 leads to the 
formation of death inducing signaling complex (DISC) (Bodmer et al., 2000). Subsequently, 
caspase 3 is directly activated by caspase 8 or indirectly through the MOMP pathway leading 
to cell death (Scaffidi et al., 1998; Suliman et al., 2001). It has been suggested that TRAIL 
might use the MOMP pathway independent of caspase 8 to induce cell death (Petak et al., 
2003). Recently it was suggested that TRAIL binding to DR5 on the cell surface is not 
necessary to induce apoptosis. Increased amount of DR5 in the cytosol during ER stress due 
to unfolded protein response may cause apoptosis without the aid of TRAIL (Lu et al., 2014). 
Other receptors that TRAIL binds to are the decoy receptors DcR1, which lacks a 
cytoplasmic domain, and DcR2, which has a truncated cytoplasmic death domain. TRAIL 
binding to these receptors does not induce apoptosis (Zauli and Secchiero, 2006).  
TRAIL has recently emerged as an important player for inducing apoptosis in virus-
infected cells (Clarke et al., 2000; Kotelkin et al., 2003). For instance, CMV-infection of 
fibroblasts and colonic epithelial cells induces expression of TRAIL, DR4 and DR5, 
rendering the infected cells sensitive to TRAIL mediated apoptosis (Sedger et al., 1999; 
Sträter et al., 2002).  Consequently, there are also viruses that have evolved strategies to 
evade TRAIL-induced apoptosis, for example adenovirus downregulates DR4 and DR5 and 
hepatitis B virus blocks DR5 expression (Benedict et al., 2001; Du et al., 2009). In addition, 
hantavirus-infected cells are protected from TRAIL-induced apoptosis through down-
regulation of cell surface DR5 (paper II).  
 
 
Figure 4. Schematic picture of TRAIL mediated cell death. 
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DR4 and DR5 can be translocated to the nucleus, thus protecting cancer cells from TRAIL-
induced cell death (Leithner et al., 2009; Chen et al., 2012). Hantavirus-infection of 
endothelial cells leads to nuclear localization of DR5 (paper II). In some cells, protein 
mislocalisation can alter the known function of the protein. One such example for DR5 was 
shown recently, as nuclear localization of DR5 may promote proliferation of tumor cells by 
inhibition of Drosha-mediated maturation of let-7 microRNA precursor (Haselmann et al., 
2014). Inhibition of TRAIL and DR4/DR5 pathway can be important for cancer development 
during virus-infection with hepatitis B virus, as it has been suggested that hepatitis B virus 
can cause hepatocellular carcinoma via blocking TRAIL through downregulation of the death 
receptors DR4 and/or DR5 (Yano et al., 2003). Another oncogenic virus, human papilloma 
virus uses its E5 protein to block TRAIL-mediated DISC formation (Kabsch and Alonso, 
2002). Resistance to TRAIL mediated killing has also been demonstrated for Epstein Barr 
virus (Kawanishi et al., 2002), presenting an additional oncogenic virus capable of inhibiting 
TRAIL-induced killing of infected cells.  
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HANTAVIRUS PATHOGENESIS 
 
Pathogenesis caused by hantaviruses have been studied frequently but we are still far from 
explaining the cause of HFRS or HCPS. Hantavirus pathogenesis is mostly considered to be 
immune-mediated but direct effects of the virus-infection may also contribute to 
pathogenesis. One important aspect of hantavirus related pathogenesis might be their 
relationship to cell death. One of the greatest challenges to explain hantavirus pathogenesis is 
due to the lack of good in vivo models. The best model so far that recapitulates that which is 
observed in humans is the macaque, nonhuman primate, model (Yanagihara et al., 1988; 
Groen et al., 1995; Klingström et al., 2002; McElroy et al., 2002; Klingström et al., 2005; 
Sironen et al., 2008; Klingström et al., 2008; Safronetz et al., 2014). Another model used, is 
the Syrian hamster model (Hooper et al., 2001, Safronetz et al., 2011; Safronetz et al., 2012; 
Brocato et al., 2014). Most of the studies done to explore hantavirus pathogenesis are in vitro 
experiments. In many cases clinical samples from hantavirus-infected patients have been 
analyzed and associations to pathogenesis have been suggested.      
The release of cytokines in the vascular system likely plays an important role during 
hantavirus-infection. Numerous studies have been done in patient samples to evaluate 
cytokine levels during HFRS and HCPS (Borges et al., 2008; Saksida et al., 2011; Li et al., 
2012; Kyriakidis and Papa 2013; Morzunov et al., 2015; Bondu et al., 2015; Baigildina et al., 
2015). The results in these studies vary but the major coherent finding is that there are 
changes in cytokine levels during HFRS and HCPS. Thus, this imbalance of cytokine levels 
can be considered to be a part of the pathogenesis. Elevated levels of IL-2, IL-6, IL-8 and 
TNF have been recorded in acute PUUV-infection (Sadhegi et al., 2011), and elevated levels 
of IL-6 has been suggested as a marker for disease severity during PUUV-infection (Outinen 
et al., 2010). Very recently it was showed, using an in vitro 3-dimensional air-exposed 
organotypic human lung tissue model, that ANDV-infection cause a late and prolonged effect 
on IL-6, IL-8, INF-γ-induced protein-10, and vascular endothelial growth factor A (VEGF-A) 
responses (Sundström et al., 2016). In fatal case of HCPS, high levels of proinflammatory 
cytokine producing immune cells have been found (Mori et al., 1999). 
 VEGF has been implicated to have important roles in hantavirus pathogenesis. VEGF 
causes vascular permeabilization through degrading the adherens junction protein vascular 
endothelial-cadherin (Vestweber, 2007). Increased levels of VEGF have been observed in 
HFRS and HCPS patients, and in vitro studies show that hantavirus-infection of endothelial 
cells renders the endothelial cells sensitive to permeabilization by VEGF (Gavrilovskaya et 
al., 2008; Shrivastava-Ranjan et al., 2010; Ma et al., 2012; Li et al., 2012; Tsergouli and 
Papa, 2013). It was also suggested that high levels of VEGF during convalescence phase of 
HFRS may contribute to renal recovery in patients (Ma et al., 2012). In the ANDV-infected 
3D air-exposed organotypic human lung tissue model, no obvious adverse effects on the 
model were observed, even though prolonged elevated levels of extracellular VEGF-A was 
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detected (Sundström et al., 2016). In a recent study, using an in vitro capillary blood vessel-
like system, it was suggested that in contrast to monolayer cells, vascular endothelial-
cadherin is not degraded during hantavirus-infection (Taylor et al., 2013). Further, in the 
same study it was shown that activation of kallikrein-kinin system and bradykinin, causing 
increased permeabilization of the capillary blood vessel-like model, during hantavirus-
infection could have an impact on pathogenesis. This permeabilization was decreased by 
inhibition of kallikrein-kinin system and bradykinin (Taylor et al., 2013). Severe cases of 
PUUV-infection have been successfully treated with bradykinin receptor antagonist (Antonen 
et al., 2013; Vaheri et al., 2014). However, it is difficult to yet draw any clear conclusion 
about these successful treatments since PUUV-infection compared to other hantavirus-
infection is consider to be mild, due to its low case fatality rate.  
Hantavirus might directly cause increased cellular permeability, by increased expression 
of the cellular microRNA miR-126 and the miR-126 associated proteins sprouty-related 
EVH1 domain containing protein 1 (SPRED1) and phosphoinositide-3-kinase, regulatory 
subunit 2 during ANDV-infection (Pepini et al., 2010). Knocking down SPRED1 in ANDV-
infected cells decreased cellular permeability (Pepini et al., 2010). In HTNV- and PHV-
infected macrophages and endothelial cells, subsets of microRNA were expressed differently. 
These microRNAs were associated with inflammatory and innate immune signaling 
pathways (Shin et al., 2013).  
Cells expressing hantavirus N protein, introduced with viral vectors rather than 
hantavirus-infection, can be killed by CTLs (Van Epps et al., 1999; Van Epps et al., 2002; 
Safronetz et al., 2009), and it has been suggested that CTL may cause vascular permeability 
by killing infected cells (Terajima et al., 2007; Schönrich et al., 2008). Corroborating this, 
strong T cell responses have been reported during hantavirus-infection in patients 
(Linderholm et al., 1993; Kilpatrick et al., 2004; Lindgren et al., 2011; Xie et al., 2013). In 
contrast, autopsies from patients does not seem to display any obvious demise of infected 
cells (Duchin et al., 1994; Zaki et al., 1995; Nolte et al., 1995). An explanation for this 
dichotomy could be that hantavirus-infection protects cells from cytotoxic lymphocyte 
mediated apoptosis (paper I). Additionally, depletion of T cells in a Syrian golden hamster 
HCPS-model did not have any effect on the disease outcome (Hammerbeck and Hooper, 
2011; Prescott et al., 2013), indicating that T cells may not be involved in hantavirus 
pathogenesis.   
Long-term consequences of hantavirus-infection have been demonstrated. For instance, 
following HFRS the risk for lymphoma is increased (Klingström et al., 2014). Cardiovascular 
causes of death in HFRS patients early after recovery from HFRS, have been reported 
(Connolly-Andersen et al., 2013). Long-term hormonal deficiencies with outcome such as 
chronic subclinical testicular failure have been reported (Mäkelä et al., 2010). It can be 
speculated that hantavirus-pathogenesis might be extended long after recovery from HFRS, 
and with consequences that are virtually impossible to predict.    
  21 
2 AIM 
 
Different pathogenesis models for hantavirus-infection have been proposed. One of the 
potential mechanism might be that hantavirus-infected endothelial cells are killed by 
cytotoxic lymphocytes, thus causing vascular leakage. This proposal is conflicting with 
several published work, and not clearly evaluated. The general aim for this thesis is to 
provide a better understanding of how hantaviruses might cause pathogenesis. This was done 
by studying if hantavirus-infection protects cells from apoptosis and if hantaviruses can 
change normal cytotoxic lymphocyte functions.  
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3 RESULTS AND DISCUSSION  
 
Inhibition of chemically-induced apoptosis 
Previous studies have shown that hantaviruses do not cause apoptosis in vitro 
(Hardestam et al., 2005), although, they might cause apoptosis in bystander cells (Markotic et 
al., 2003). If seen by a virus point of view, inhibition or at least delay of apoptosis can be 
crucial, since the virus needs a host cell for its propagation. Therefore, investigation was 
made to see if hantaviruses can inhibit apoptosis. To study this, hantavirus-infected cells and 
uninfected cells were treated with the kinase inhibitor STS. Apoptosis was observed in STS-
treated uninfected cells, in contrast, hantavirus-infection protected cells from STS-induced 
apoptosis (Figure 5). Caspase 3-activity was studied, and in comparison to uninfected cells, 
hantavirus-infected cells had lower levels of caspase 3 activity post STS-treatment (paper I). 
 
 
Figure 5. Epithelial cells infected with hantavirus (green) treated with STS and TUNEL (red) was measured. 
Nuclei were counterstained with DAPI (blue). 
 
Further, the direct effect on caspase 3 by hantaviruses was explored. As the hantavirus N 
protein is multifunctional (Ye et al., 2001; Li et al., 2002; Mir and Panganiban 2008; Taylor 
et al., 2009a; Ontiveros et al., 2010), we proposed that the N protein might also have 
functions that somehow affected caspase 3. In silico studies revealed putative caspase 3 
cleavage sites in hantavirus N protein, and interaction between the N protein and caspase 3 
was established by showing that caspase 3 could cleave the N protein. Moreover, ANDV N 
protein in infected cells was cleaved during STS-treatment and this cleavage was inhibited by 
addition of the pan caspase inhibitor Z-VAD prior to STS-treatment. Importantly, we showed 
that recombinant N protein inhibits caspase 3 activity. Caspase 3 is a cysteine protease that 
cleave proteins after aspartic acid, and the canonical cleavage site is DEVD (aspartic acid-
glutamic acid-valine-aspartic acid). DLID285 (aspartic acid-leucine-isoleucine-aspartic acid) 
was identified as the caspase 3 site in ANDV N protein. The inhibition of STS-mediated 
apoptosis could also be seen in wild type ANDV N protein transfected cells. However, if a 
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mutation was introduced in the caspase 3 site, from DLID285 to DLIA285 (aspartic acid-
leucine-isoleucine-aspartic acid), the apoptosis-resistance was reverted (paper I). Other 
studies also show that hantavirus N protein is important for modulating apoptosis, certain 
deletions in HTNV N protein render transfected cells prone to apoptosis (Ontiveros et al., 
2010).    
In previous studies, attempts to induce apoptosis in hantavirus-infected cells to 
investigate the effect of this on the virus-infected cell were not reported. Direct effect on 
apoptosis induction during virus-infection was studied, where it was believed that 
hantaviruses caused apoptosis (Kang et al., 1999; Li et al 2004; Li et al., 2005). It has also 
been suggested that hantavirus might cause apoptosis in bystander cells (Markotic et al., 
2003). Thus, by inducing apoptosis with STS, we could study if hantavirus infected cells are 
susceptible or resistance to apoptosis. Hantavirus-infection of both primary cells and cell 
lines protects them from chemically induced apoptosis. Taken together, it could be proposed 
that hantavirus N protein might act as a decoy that inhibits caspase 3-dependent apoptosis 
(paper I). In this aspect, it has been shown that Junin virus, another hemorrhagic fever 
causing virus, uses its nucleoprotein as a decoy to inhibit the induction of apoptosis during 
infection (Wolff et al., 2013).                
 
Inhibition of cytotoxic granule-mediated apoptosis 
In an effort to place this inhibition of apoptosis in a biological context, studies were 
performed to determine if cytotoxic lymphocytes may induce apoptosis in hantavirus-infected 
cells. NK cells, isolated from healthy donors, were used as a model for cytotoxic lymphocytes 
and infected primary human endothelial cells were used as the target cells. NK cells were 
activated with IL-2, and HLA class I on the uninfected and hantavirus-infected target cells 
was blocked. Activated NK cells were co-incubated with HLA class I-blocked target cells 
and degranulation of the cytotoxic granula was measured by studying CD107 surface 
expression on the NK cells. Similar degranulation towards both hantavirus-infected and 
uninfected cells was seen in when HLA class I was blocked on the target cells. These NK 
cells were able to kill uninfected cells by inducing apoptosis in them, but hantavirus-infected 
cells on the other hand were not killed by the NK cells, showing that hantaviruses protect 
infected cells from induction of apoptosis by NK cells. In line with this findings, it was also 
shown that NK cells failed to induce caspase 3 activity in hantavirus-infected endothelial 
cells (paper I).   
Inhibition of caspase 3 activity might explain how hantaviruses inhibit STS-mediated 
apoptosis but it does not entirely account for inhibition of cytotoxic granule-mediated cell 
death. Granzyme B, a key player during cytotoxic granule dependent caspase 3-mediated 
apoptosis, is also an inducer of cell death independently of caspase 3 activation (Heibein et 
al., 1999), indicating that blocking granzyme B activity could be important for hantaviruses. 
For example, adenovirus L4-100K assembly protein and CrmA potently and directly inhibit 
  25 
granzyme B (Tewari et al., 1995; Quan et al., 1995; Andrade et al., 2001). As hantavirus N 
protein inhibits caspase 3 activity, could it also harbor a way to inhibit granzyme B activity? 
In silico experiments revealed putative granzyme B sites in the N protein (our unpublished 
data). Interaction between hantavirus N protein and granzyme B was established, as 
granzyme B could cleave the hantavirus N protein at several sites. ANDV N protein strongly 
inhibited granzyme B activity and this inhibitory effect lasted for a long time (paper I). 
Granzyme B can be translocated to the nucleus, possibly with the aid of importin, where it 
may cause cell death (Trapani et al., 1996; Jans et al., 1996, Blink et al., 2005). Hantavirus N 
protein interact with importin-α and prevents its transport capacity to the nucleus (Taylor et 
al., 2009a). Taken together, N protein can directly inhibit granzyme B (paper I) and maybe 
have the ability to indirectly limit its transport to the nucleus.    
By showing that hantaviruses effectively blocks the function of granzyme B and caspase 
3, it can be concluded that the cytotoxic lymphocytes, e.g. NK cells, and CD8+ T cells, that 
use cytotoxic granule-mediated pathway to induce apoptosis in infected cells, will not be able 
to eradicate hantavirus-infected cells (paper I). A few mechanisms for granzyme B inhibition 
by viruses have been proposed. For instance, serine proteinase inhibitor (serprin)-mediated 
granzyme B inhibition, where the serpin irreversibly binds its target. The best known viral 
serpin is the cowpox virus encoded CrmA (Chowdhury and Lieberman 2008). CrmA acts as 
serpin for caspases too (Ray et al., 1992). Another mechanism was shown by Andrade and 
colleagues: adenovirus L4-100K protein efficiently blocks granzyme B activity by acting as a 
decoy, as it takes very long time for granzyme to cleave this protein (Andrade et al., 2001). 
Both CrmA and adenovirus L4-100K protein act directly on granzyme B, but other 
mechanisms have been suggested as well. For example, parainfluenza virus type 3 can inhibit 
granzyme B in infected T-cells by blocking granzyme B mRNA transcription (Sieg et al., 
1995). Hantaviruses, only encode four to five proteins, in contrast to poxvirus and adenovirus 
which express 20-200 viral proteins. In this regard, it is astonishing that a small virus like 
hantavirus could also harbor the similar potential as the viruses that expresses many more 
proteins. Whether hantavirus N protein acts as a serpin or a decoy for granzyme B is currently 
unknown. It would be interesting to identify all the granzyme B cleavage sites in the 
hantavirus N protein and explore which site(s) that might be important for granzyme B 
inhibition. Interestingly, adenovirus L4-100K protein, which is cleaved into several fragments 
only need one of the cleavage sites to inhibit granzyme B. If one may speculate, it seems 
likely that hantavirus N protein, abundantly expressed in an infected cell and being cleaved 
by granzyme B, may perhaps act as a decoy for granzyme B, similarly as I also proposed for 
N protein mediated caspase 3 inhibition.  
In contrast to what is presented in this thesis, hantavirus nucleocapsid expressing target 
cells have been shown to be killed by T-cells. In these cases the hantavirus protein expression 
was dependent on viral vectors, rather than hantavirus-infection (Van Epps et al., 1999; Van 
Epps et al., 2002; Safronetz et al., 2009). So, this raises the question, why are cells expressing 
hantavirus N protein not protected from T-cell mediated killing? One possibility is that virus 
replication is needed to block cytotoxic lymphocyte mediated cell death. Cytotoxic 
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lymphocytes use granzyme H to circumvent adenovirus L4-100K protein mediated granzyme 
B resistance, via cleaving the virus protein, thus incapacitating the virus protein (Andrade et 
al., 2007). If this or something similar could be the case also for hantavirus N expressing cells 
remains to be elucidated. Further explanation could be that cytotoxic lymphocytes use other 
ways than the cytotoxic granule pathway to kill target cells. However in this case the N 
protein expressing cells might still be protected, since N protein inhibits caspase 3 activity. 
Nevertheless, if caspase 3 independent cell death is induced, this might render N expressing 
cells susceptible to lysis by the CTLs.  
 
Inhibition of a death ligand/receptor pathway 
Showing inhibition of cytotoxic granule dependent apoptosis explains that one major 
pathway used by cytotoxic lymphocytes to induce cell death is blocked by hantaviruses. 
Another major pathway used by these lymphocytes to kill cells is the death ligand/receptor 
pathway. One of the main death ligands used to induce apoptosis is TRAIL. To study if 
TRAIL-induced apoptosis is also inhibited by hantavirus-infection, endothelial cells were 
infected with HTNV and four days post infection they were treated with TRAIL. TRAIL 
caused cell death in uninfected cells but as expected hantavirus-infected cells were not killed 
(paper II).   
To find out how this inhibition of TRAIL-induced apoptosis occurred different key 
molecules of the death receptor mediated pathway were studied. It was demonstrated in 
paper I that hantavirus N protein can inhibit caspase 3 activity, indicating that this inhibition 
might be important for inhibition of TRAIL-induced apoptosis. However, while TRAIL 
triggered activation of caspase 8 and caspase 3 in uninfected cells it did not in the HTNV-
infected cells, therefore it was concluded that inhibition of caspase 3 is not needed for 
hantavirus-mediated inhibition of TRAIL-induced apoptosis (paper II). TRAIL can induce 
cell death by MOMP pathway via cytochrome C release to the cytoplasm, and without the aid 
of caspases (Suliman et al 2001). So release of cytochrome C was studied. TRAIL caused 
cytochrome C release in uninfected, but not in the infected cells, showing that inhibition 
cytochrome C release is also not necessary for hantavirus-mediated inhibition of TRAIL-
induced apoptosis (paper II).  
Viruses such as hepatitis B virus and adenovirus, deregulate the TRAIL death receptors 
DR4 and DR5 (Benedict et al., 2001; Du et al., 2009). Hence, we suggested that hantavirus-
infection might cause changes in DR4 and DR5 levels in infected cells. DR4 was not detected 
in any of the endothelial cells, infected or uninfected. Similar levels of full-length DR5 was 
detected in both HTNV-infected and uninfected cells. Moreover, an additional smaller DR5 
band was detected in the infected endothelial cells, which remarkably was not seen in the 
uninfected cells. Specific cellular localization is important for death receptors in order for 
them to function normally. In this case, the receptors should be on the cell surface to be able 
to interact with TRAIL. DR5 expression on the surface of hantavirus-infected cells decreased 
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over time, whereas levels of DR5 on the uninfected cells remained unchanged. Hence, 
TRAIL cannot induce cell death in hantavirus-infected cells (paper II). 
 
Aberrant localization of death receptor 5 
It has been suggested that increased levels of DR5 during ER stress in the cytosol may 
cause apoptosis without the binding of its cognate ligand TRAIL (Lu et al., 2014). Since the 
total amount of full-length DR5 is not changed during hantavirus infection, and might be 
increased as an additional band is formed, should DR5 in that case cause induction of 
apoptosis in the infected cells? As hantavirus infection does not cause apoptosis per se, it was 
speculated that the virus might cause aberrant localization of DR5. Cell fractionation assay 
showed that the levels of DR5 in the cytosol was decreased during infection (paper II). 
TRAIL resistance in certain cancer cells have been credited to aberrant localization of DR4 
and/or DR5 from the cell surface to the cell nucleus (Leithner et al., 2009; Chen et al., 2012). 
Thus, the next step was to investigate if this also was the case for hantavirus-infected cells. 
Indeed, DR5 was detected in the nucleus of hantavirus-infected cells to a higher extent than 
in uninfected cells (paper II). It is remarkable that a virus that causes acute transient 
infection in humans, harbors such a function which previously has only been demonstrated in 
cancer cells (Leithner et al., 2009; Chen et al., 2012). 
Death receptors might gain other functions due to mislocalisation. For instance, DR5 in 
the nucleus might cause cell proliferation (Haselmann et al., 2014). Cell proliferation is 
considered as one of the hallmarks of cancer, together with resistance to cell death and others 
(Hanahan and Weinberg, 2011). This piques curiosity, since following HFRS the risk for 
lymphoma increases (Klingström et al., 2014). As hantavirus-infected cells are protected 
from cell death (paper I and II), one might ask, is this long term consequence of HFRS 
directly due to virus-infection or are other factors involved? The notion that a transient 
infection may be the origin of cancer is very thought provocative. Elucidating this issue in the 
future could indeed be very interesting. Other viruses known to cause cancer are Epstein Barr 
virus, human herpes virus 8, human T-cell leukemia virus type 1 and hepatitis C virus, all of 
these causes either chronic or latent infection (Carrillo-Infante et al., 2007), and this seems to 
argue against the notion that hantaviruses could possibly be oncogenic. Although, in natural 
hosts, hantavirus-infection is chronic (Jonson et al., 2010). Could this mean that hantaviruses 
might be oncogenic? More studies are needed to explain this matter.         
 
NK cells activated by hantaviruses 
NK cell levels are elevated during HFRS (Björkström et al., 2011). To explore the NK 
cell activation in patients during HFRS, 16 Swedish PUUV-infected patients were studied. 
Peripheral blood monocytes (PBMCs) samples were collected during acute and 
convalescence phase of HFRS (Figure 6). CD56dim and CD56bright NK cells were evaluated by 
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analyzing the early activation marker CD69. During acute phase of HFRS CD56dim NK cells 
exhibited high expression of CD69, which declined over time during the convalescence 
phase. Expression of CD69 on CD56bright cells was somewhat higher during the acute phase 
but not to the same extent as on CD56dim cells. Other NK cell activating receptors such as 
NKG2D, 2B4, and the natural cytotoxicity receptors NKp30 and NKp46 were elevated on the 
CD56dim cells but not on CD56bright cells while the activating receptors DNAM-1, CD161, 
and CD16, were not changed. Intracellular levels of granzyme B and perforin were increased 
in both CD56dim and CD56bright cells (paper III).  
 
 
Figure 6. 16 PUUV-infected patients were sampled during acute (days 0-20) and early convalescence (days 60-
450) and PBMCs were isolated.  
 
The activation of CD56dim cells was closely studied in vitro to explain possible 
mechanism of how this activation may occur. Resting primary NK cells were isolated from 
healthy donors and exposed to HTNV to induce activation. These NK cells were not infected 
by HTNV and nor were they activated after direct exposure to virus particles, thus suggesting 
that HTNV cannot directly cause activation of CD56dim cells. Next step was to examine if 
HNTV infected endothelial and epithelial cells could somehow activate NK cells. Isolated 
primary NK cells were co-incubated with HTNV-infected primary endothelial and epithelial 
cells. As activation markers, the expression levels of CD69 and CD38 expression on both 
CD56dim and CD56bright cells were measured. Clear activation of CD56dim cells were seen, as 
indicated by increase in CD69 and CD38 levels. CD56bright cells also showed activation but to 
a much lower level than that seen in CD56dim cells. To show if this activation was cell to cell 
contact dependent or due to some factors in the supernatant, the NK cells were separated 
from the target cells using a transwell system. NK cells separated by transwells showed no 
obvious signs of activation, which suggests that the activation is cell to cell contact dependent 
(paper III).  
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Activation through interleukin-15 
Virus-infection can cause changes in IL-15 expression (Fawaz et al., 1999; Zhou et al., 
2007; Zdrenghea et al., 2012; Jabri and Abadie 2015), and IL-15 is essential for NK cell 
activation (Jabri and Abadie 2015). mRNA levels of both IL-15 and IL-15Rα were increased 
in HTNV-infected endothelial and epithelial cells compared to uninfected cells (paper III). 
The surface levels of IL-15 and IL-15Rα were measured by flow cytometry and as with 
mRNA levels, levels of IL-15 and IL-15Rα were increased on the virus-infected endothelial 
and epithelial cells (paper III). Additionally, to test the significance of IL-15, anti-IL-15 
neutralizing antibodies were used to block IL-15 on HTNV-infected cells surface and then 
NK cells were co-incubated with the infected cells. Blocking of IL-15 on the infected cells 
inhibited NK cells activation, as displayed by decreased CD69 expression. Therefore, it was 
concluded that trans-presentation of IL-15 on the hantavirus-infected cell surface is an 
important factor for activation of NK cells, at least in vitro (paper III).  
It has been shown that several viruses, both DNA and RNA (positive and negative sense 
RNA), including Human herpesvirus-6, Human herpesvirus-7, herpes simplex virus, Epstein-
Barr virus, respiratory syncitial virus, vesicular stomatitis virus, influenza virus, reovirus, and 
rotavirus, induce IL-15 (Flamand et al., 1996; Atedzoe et al., 1997; Fawaz et al., 1999; Zhou 
et al., 2007; Zdrenghea et al., 2012). In this regard, it is not very surprising that hantavirus 
also cause induction of IL-15. This shows that IL-15 is a common key cytokine expressed 
during many virus-infections. Supporting the findings from paper III are reports that show 
that both IL-15 is elevated in HFRS patients (Björkström et al., 2011) and also in SNV-
infected non-human primates (Safronetz et al., 2014).   
 
An unexpected function of hantavirus activated NK cells 
HFRS patients exhibit increased levels of granzyme B, perforin, lactate dehydrogenase, 
cleaved cytokeratin 18,  and cell free DNA (Klingström et al., 2006; Outinen et al., 2012), 
indicating tissue damage during disease. As shown so far in this thesis and by others, 
hantaviruses protects cells from programmed cell death (paper I and II, Ontiveros et al., 
2010). How might these tissue damage be explained then? Studies show that cytotoxic 
lymphocytes are highly activated during human hantavirus-infection (Kilpatrick et al., 2004; 
Björkström et al., 2011; Lindberg et al., 2011). In vitro, NK cells are activated by hantavirus-
infected cells via IL-15 and IL-15Rα (paper III). Could these NK cells be behind the cause 
of the observed damage?  
As shown above, NK cells are activated by hantavirus-infected cells (paper III). To 
explore if these hantavirus-activated NK cells had gained any functional ability, effector 
responses against NK cell-sensitive K562 cells were tested. After co-incubation with HTNV-
infected cells NK cells showed increased degranulation, IFN-γ-, and TNF-responses towards 
K562 cells, resulting in increased specific lysis of the K562 cells. The response towards 
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endothelial cells was also tested. Here, the NK cells were activated with either IL-15 or IFN-
α and co-incubated with HTNV-infected or uninfected endothelial cells. The activated NK 
cells displayed increased degranulation, IFN-γ-, and TNF-responses towards uninfected 
endothelial cells. Similar but considerably lower responses by activated NK cells towards 
HTNV-infected cells were seen. This difference was attributed to increased levels of HLA 
class I on the HTNV-infected cell surface, as blocking of HLA class I in both uninfected and 
infected cells increased the NK cell responses towards the hantavirus infected cells (paper 
III).  
Finally, could CD56dim NK cells activated by HTNV-infected endothelial cells gain 
additional funtions? To investigate this, NK cells were co-incubated with uninfected cells or 
HTNV-infected cells. Twenty-four hours post incubation NK cells were transferred to new 
cells, either infected or uninfected and co-incubated for five hours (Figure 7). Then the NK 
cells were removed and the target endothelial cells were studied. Despite normal HLA class I 
levels, uninfected endothelial cells were killed by NK cells that were activated by HTNV-
infected cells. The infected cells were protected due to increased levels of HLA class I, and if 
targeted also through inhibition of granzyme B and TRAIL-mediated cell death. Taken 
together, this suggests that NK cells are activated by IL-15 on HTNV-infected cells, and this 
activation might cause NK cells to break the normal HLA class I-mediated self-tolerance and 
kill uninfected cells (paper III). The specific mechanism of how NK cells activated by 
hantavirus-infected cells can kill uninfected cells has not been explored in this thesis. It 
would be interesting to see by which means the activated NK cells kill the uninfected 
endothelial cells. 
 
 
Figure 7. Schematic picture of the experimental setup. NK cells were co-incubated with uninfected or HTNV-
infected HUVECs for 24 hours and then transferred to new sets of cells (uninfected or HTNV-infected) and 
again co-incubated for five hours.  
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It is not uncommon that virus infection increases NK cell toxicity (Flamand et al., 1996; 
Atedzoe et al., 1997; Fawaz et al., 1999), and this was also shown for HTNV-infection 
(paper III). Nevertheless, to the best of my knowledge, it has never been shown that 
activation of NK cells directly or indirectly through virus-infection causes NK cells to kill 
uninfected cells. Moreover, it was striking that this killing occurred on target uninfected cells 
despite their normal levels of HLA class I.  
Thus, a hypothesis for hantavirus-mediated pathogenesis might be proposed: 
NK cells activated by hantavirus-infected cells might kill bystander uninfected cells which 
might partly explain the vascular leakage seen during HFRS and HCPS.  
 
Altogether, the three papers presented in this thesis show different ways that hantaviruses 
use to inhibit the killing effect of cytotoxic lymphocytes. Further, hantavirus-infected cells 
activates NK cells and cause NK cells to target and destroy uninfected cells.  
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CONCLUSIONS 
 
The studies presented in this thesis shows that hantavirus-infected cells are protected 
from cytotoxic lymphocyte mediated programmed cell death (paper I and II), and that NK 
cells are activated by hantavirus-induced IL-15/IL-15Rα expression (paper III).  
In detail, this thesis demonstrate that hantavirus-infected cells are protected from 
cytotoxic granule mediated pathway. This was attributed to virus N protein mediated 
inhibition of granzyme B and caspse 3. Hantavirus N protein inhibit caspase 3 mediated 
apoptosis, and the site DLID285 in the N protein was shown to be important for this inhibition 
(paper I).   
Hantavirus-infected cells are protected from TRAIL-mediated apoptosis. Virus-infection 
causes down-regulation of DR5 on the infected cell surface. DR5 is translocated to the 
nucleus during hantavirus-infection (paper II).  
During acute HFRS CD56dim NK cells are activated. In vitro, these NK cells are activated 
by hantavirus-infected cells. This activation is cell to cell contact dependent and is explained 
by IL-15/IL-15Rα expression on the infected cell surface. These activated NK cells induce 
apoptosis in uninfected cells with normal HLA class I levels (paper III).  
Taken together, hantavirus-infection confers resistance to cytotoxic lymphocyte 
mediated apoptosis by inhibition of granzyme B, caspse 3 and down-regulation of cell surface 
DR5. The virus affects NK cells in such way, that the NK cells get activated and then starts to 
kill uninfected cells (Figure 8).  
These works have been attempted to shed more light to the understanding of hantavirus 
pathogenesis. Although, to understand the entire characteristic of HFRS and HCPS caused 
pathogenesis more basic research combined with translational research will be required.   
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Figure 8. Illustration of hantaviruses inhibit cytotoxic lymphocyte mediated killing and how they activate NK 
cell, which cause cell death of uninfected cell. 
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“You either die a hero or you live long enough to see yourself become the villain” 
- Harvey Dent from The dark knight  
